利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

153 条记录 (耗时 0.026 秒)

    Thienodiazepine derivatives
    1.
    发明授权
    Thienodiazepine derivatives 失效
    噻吩并二氮杂衍生物

    公开(公告)号：US4017620A

    公开(公告)日：1977-04-12

    申请号：US575727

    申请日：1975-05-08

    申请人： Yutaka Kuwada ,  Kanji Meguro ,  Hiroyuki Tawada ,  Takashi Sohda ,  Hideaki Natsugari ,  Yoshiaki Sato

    发明人： Yutaka Kuwada ,  Kanji Meguro ,  Hiroyuki Tawada ,  Takashi Sohda ,  Hideaki Natsugari ,  Yoshiaki Sato

    IPC分类号： A61K31/55 ,  A61P25/00 ,  A61P25/20 ,  C07D495/14

    CPC分类号： C07D495/14

    摘要： There is disclosed new thienodiazepine derivatives of the general formula: ##STR1## wherein R.sup.1 represents a carboxyl group which may be esterified or amidated; each of R.sup.2 and R.sup.3 represents hydrogen atom or a lower alkyl group, or R.sup.2 and R.sup.3 may bond to each other to form an alkylene group; R.sup.4 represents a phenyl group which may have substituent; and R represents hydrogen atom, an acyl group or an alkyl group, or its pharmaceutically acceptable acid addition salts. The above compounds are useful as medicine in human and animal therapy, which act on the central nervous system, for example, as muscle relaxants, anticonvulsants, sedatives, minor tranquilizers, etc.

    摘要翻译： 公开了以下通式的新的噻吩并二氮杂衍生物：其中R 1表示可被酯化或酰胺化的羧基; R 2和R 3各自表示氢原子或低级烷基，或者R 2和R 3可以彼此键合形成亚烷基; R4表示可以具有取代基的苯基; R表示氢原子，酰基或烷基，或其药学上可接受的酸加成盐。 上述化合物可用作人和动物治疗中的药物，其作用于中枢神经系统，例如肌肉松弛剂，抗惊厥药，镇静剂，微量镇静剂等。

    4-Pyridine carbonyl phenyl 1,2,4 triazoles
    3.
    发明授权
    4-Pyridine carbonyl phenyl 1,2,4 triazoles 失效
    4-吡啶羰基苯基1,2,4-三唑

    公开(公告)号：US4044129A

    公开(公告)日：1977-08-23

    申请号：US592889

    申请日：1975-07-03

    申请人： Yutaka Kuwada ,  Kanji Meguro ,  Hideaki Natsugari ,  Yoshiaki Sato ,  Hiroyuki Tawada

    发明人： Yutaka Kuwada ,  Kanji Meguro ,  Hideaki Natsugari ,  Yoshiaki Sato ,  Hiroyuki Tawada

    IPC分类号： C07D401/04 ,  A61K31/44 ,  A61K31/4427 ,  A61K31/535 ,  A61P21/02 ,  A61P25/00 ,  A61P25/08 ,  A61P25/20 ,  C07D213/50 ,  C07D249/08 ,  C07D401/10 ,  C07D413/14

    CPC分类号： C07D249/08 ,  C07D213/50

    摘要： A novel triazole derivative of the general formula (I): ##STR1## wherein R.sup.1 and R.sup.2, which may be the same or different, represent alkyl group or aralkyl group and one of R.sup.1 and R.sup.2 may be hydrogen atom, or R.sup.1 and R.sup.2 form a heterocyclic ring together with the nitrogen atom adjacent thereto; R.sup.3 represents hydrogen atom or a hydrocarbon residue; R.sup.4 represents hydrogen atom or a lower alkyl group; Py represents a pyridyl group; and the ring A is either unsubstituted or substituted by halogen atom, nitro, alkyl, alkoxy or trifluoromethyl group, and pharmaceutically acceptable acid addition salts thereof are found to be useful as medicine in human and animal therapy, as these compounds act on the central nervous as for example, muscle relaxants, anticonvulsants, sedatives, minor tranquilizers, etc.

    摘要翻译： 通式（I）的新的三唑衍生物：（I）其中R 1和R 2可以相同或不同，表示烷基或芳烷基，R 1和R 2之一可以是氢原子或R 1 R2与邻近的氮原子一起形成杂环; R3表示氢原子或烃残基; R4代表氢原子或低级烷基; Py代表吡啶基; 发现环A是未取代的或被卤素原子取代的硝基，烷基，烷氧基或三氟甲基，其药学上可接受的酸加成盐可用作人和动物治疗中的药物，因为这些化合物作用于中枢神经 例如，肌肉松弛剂，抗惊厥药，镇静剂，小镇静剂等

    Thienopyridine-carboxylic acid derivatives
    4.
    发明授权
    Thienopyridine-carboxylic acid derivatives 失效
    噻吩并吡啶 - 羧酸衍生物

    公开(公告)号：US4079060A

    公开(公告)日：1978-03-14

    申请号：US727382

    申请日：1976-09-27

    申请人： Yutaka Kuwada ,  Kanji Meguro ,  Yoshiaki Sato ,  Takeshi Fugono

    发明人： Yutaka Kuwada ,  Kanji Meguro ,  Yoshiaki Sato ,  Takeshi Fugono

    IPC分类号： C07D495/04 ,  C07D495/14

    CPC分类号： C07D495/04

    摘要： Novel thienopyridine-carboxylic acid derivatives, which are shown by the general formula ##STR1## wherein R.sup.1 represents hydrogen or a lower alkyl; R.sup.2 represents hydrogen, a lower alkyl or a halogen, or R.sup.1 and R.sup.2, taken together, may represent an alkylene to form a 5- or 6-membered ring with or without alkyl substituents; each of R.sup.4 and R.sup.5 represents hydrogen or a lower alkyl; and their pharmaceutically acceptable salts obtainable when R.sup.4 is hydrogen, which are useful medicines such as chemotherapeutic agents of bacterial infections.

    摘要翻译： 新的噻吩并吡啶 - 羧酸衍生物，其通式为：其中R 1表示氢或低级烷基; R 2表示氢，低级烷基或卤素，或者R 1和R 2一起可以表示亚烷基以形成具有或不具有烷基取代基的5-或6-元环; R 4和R 5各自表示氢或低级烷基; 以及当R4为氢时可获得的药学上可接受的盐，其为有用的药物，例如细菌感染的化学治疗剂。

    Thienopyridine-carboxylic acid derivatives
    5.
    发明授权
    Thienopyridine-carboxylic acid derivatives 失效
    噻吩并吡啶 - 羧酸衍生物

    公开(公告)号：US3997545A

    公开(公告)日：1976-12-14

    申请号：US612743

    申请日：1975-09-12

    申请人： Yutaka Kuwada ,  Kanji Meguro ,  Yoshiaki Sato ,  Takeshi Fugono

    发明人： Yutaka Kuwada ,  Kanji Meguro ,  Yoshiaki Sato ,  Takeshi Fugono

    IPC分类号： C07D495/04 ,  C07D513/00

    CPC分类号： C07D495/04

    摘要： Novel thienopyridine-carboxylic acid derivatives, which are shown by the general formula ##STR1## wherein R.sup.1 represents hydrogen or a lower alkyl; R.sup.2 represents hydrogen, a lower alkyl or a halogen; or R.sup.1 and R.sup.2, taken together, may represent an alkylene to form a 5- or 6-membered ring with or without alkyl substituents; each of R.sup.4 and R.sup.5 represents hydrogen or a lower alkyl; and their pharmaceutically acceptable salts obtainable when R.sup.4 is hydrogen, which are useful medicines such as chemotherapeutic agents of bacterial infections.

    摘要翻译： 新的噻吩并吡啶 - 羧酸衍生物，其通式为：其中R 1表示氢或低级烷基; R2代表氢，低级烷基或卤素; 或者R 1和R 2一起可以表示亚烷基以形成具有或不具有烷基取代基的5-或6-元环; R 4和R 5各自表示氢或低级烷基; 以及当R4为氢时可获得的药学上可接受的盐，其为有用的药物，例如细菌感染的化学治疗剂。

    Thienopyridine-carboxylic acid derivatives
    6.
    发明授权
    Thienopyridine-carboxylic acid derivatives 失效
    噻吩并吡啶 - 羧酸衍生物

    公开(公告)号：US3951989A

    公开(公告)日：1976-04-20

    申请号：US490704

    申请日：1974-07-22

    申请人： Yutaka Kuwada ,  Kanji Meguro ,  Yoshiaki Sato ,  Takeshi Fugono

    发明人： Yutaka Kuwada ,  Kanji Meguro ,  Yoshiaki Sato ,  Takeshi Fugono

    IPC分类号： C07D333/36 ,  C07D333/38 ,  C07D333/66 ,  C07D333/68 ,  C07D495/04 ,  C07D213/28

    CPC分类号： C07D495/04 ,  C07D333/36 ,  C07D333/38 ,  C07D333/66 ,  C07D333/68

    摘要： Novel thienopyridine-carboxylic acid derivatives, which are shown by the general formula ##SPC1##Wherein R.sup.1 represents hydrogen or a lower alkyl; R.sup.2 represents hydrogen, a lower alkyl or a halogen; or R.sup.1 and R.sup.2, taken together, may represent an alkylene to form a 5- or 6-membered ring with or without alkyl substituents; each of R.sup.4 and R.sup.5 represents hydrogen or a lower alkyl; and their pharmaceutically acceptable salts obtainable when R.sup.4 is hydrogen, which are useful medicines such as chemotherapeutic agents of bacterial infections.

    摘要翻译： 新的噻吩并吡啶 - 羧酸衍生物，其通式如下：其中R1表示氢或低级烷基; R2代表氢，低级烷基或卤素; 或者R 1和R 2一起可以表示亚烷基以形成具有或不具有烷基取代基的5-或6-元环; R 4和R 5各自表示氢或低级烷基; 以及当R4为氢时可获得的药学上可接受的盐，其为有用的药物，例如细菌感染的化学治疗剂。

    Muscle training apparatus and belt for muscle training
    7.
    发明授权
    Muscle training apparatus and belt for muscle training 有权
    肌肉训练器械和肌肉训练带

    公开(公告)号：US08992397B2

    公开(公告)日：2015-03-31

    申请号：US12674839

    申请日：2008-08-19

    申请人： Yoshiaki Sato

    发明人： Yoshiaki Sato

    IPC分类号： A63B21/008 ,  A61F13/00 ,  A61F13/06 ,  A61F15/00 ,  A63B23/12 ,  A61H9/00 ,  A61H11/00 ,  A63B21/00

    CPC分类号： A63B23/12 ,  A61H9/0078 ,  A61H9/0092 ,  A61H11/00 ,  A61H2201/5038 ,  A61H2201/5071 ,  A61H2205/06 ,  A61H2205/10 ,  A63B21/0085 ,  A63B21/4011 ,  A63B21/4017 ,  A63B21/4025 ,  A63B23/03508 ,  A63B23/0355 ,  A63B23/1209 ,  A63B69/0059 ,  A63B2208/053 ,  A63B2209/10 ,  A63B2213/006 ,  A63B2220/56

    摘要： To ensure easy and secure placement of a belt for KAATSU muscle training on a target compressed site near the proximal portion of a limb.A belt 100B has a longer first band-shaped member 110 and a shorter second band-shaped member 120 both of which have a band shape and are connected to a ring-shaped joint member 130 at their respective ends. In order to place the belt 100B on the target compressed site, the limb (right leg in this case) on which the belt 100B is expected to be placed is inserted into a loop of the first band-shaped member 110 formed by passing the end of the first band-shaped member 110 through an opening in the joint member 130, and the belt is moved up to the target compressed site. Then, the first band-shaped member 110 and the second band-shaped member 120 are pulled with both hands in the opposite directions. The belt 100B is placed on the target compressed site with the belt 100B being tensioned appropriately.

    摘要翻译： 为了确保在肢体近端部位附近的目标压缩部位上容易且安全地放置用于KAATSU肌肉训练的腰带。 带100B具有较长的第一带状构件110和较短的第二带状构件120，它们都具有带状并且在它们各自的端部处连接到环形接头构件130。 为了将皮带100B放置在目标压缩部位上，期望将皮带100B放置在其上的肢体（在这种情况下为右腿）被插入到通过使端部形成的第一带状部件110的环中 的第一带状构件110通过接头构件130中的开口，并且带被移动到目标压缩位置。 然后，第一带状构件110和第二带​​状构件120用双手在相反的方向拉动。 皮带100B被放置在目标压缩部位上，带100B被适当张紧。

    Muscle Building Tool and Control Method Thereof
    8.
    发明申请
    Muscle Building Tool and Control Method Thereof 审中-公开
    肌肉建筑工具及其控制方法

    公开(公告)号：US20140324097A1

    公开(公告)日：2014-10-30

    申请号：US14358833

    申请日：2012-02-27

    申请人： Yoshiaki Sato

    发明人： Yoshiaki Sato

    IPC分类号： A61B17/12

    CPC分类号： A61B17/12 ,  A61B5/0053 ,  A63B21/4025 ,  A63B23/03508 ,  A63B23/0494 ,  A63B23/1281 ,  A63B24/0062 ,  A63B71/0622 ,  A63B2071/0627 ,  A63B2213/006 ,  A63B2220/56

    摘要： A muscle building tool 1 is used to build, by applying a predetermined pressure to at least one of a user's four limbs to restrict blood flow, a muscle of the limb, and includes: a belt 10 that is wrapped around the at least one of the four limbs and applies the pressure to the muscle; a fastener 40 that maintains a loop shape of the belt 10 in a state of applying the pressure to the muscle; a tension sensor 60 that measures a tension acting on the belt 10 when wrapping the belt 10; and a pressure sensor that is configured to automatically start an operation when the tension measured by the tension sensor 60 exceeds a predetermined threshold, and measures the pressure applied to the muscle.

    摘要翻译： 肌肉建筑工具1用于通过向用户的四肢中的至少一个施加预定的压力来建立肢体的肌肉，并且包括：围绕所述至少一个 四肢并施加压力到肌肉; 紧固件40，其将皮带10的环形状保持在对肌肉施加压力的状态; 张力传感器60，其测量当缠绕带10时作用在带10上的张力; 以及压力传感器，其被构造成当由张力传感器60测量的张力超过预定阈值时自动开始操作，并且测量施加到肌肉的压力。